News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,510 Results
Type
Article (11011)
Company Profile (27)
Press Release (82468)
Multimedia
Podcasts (97)
Webinars (13)
Section
Business (34993)
Career Advice (553)
Deals (6052)
Drug Delivery (119)
Drug Development (12953)
Employer Resources (44)
FDA (2024)
Job Trends (2187)
News (50959)
Policy (4896)
Tag
2025 Best Places to Work (2)
2026 Best Places to Work (4)
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 NextGen (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (177)
Accelerated approval (11)
ADA (13)
Adcomms (21)
Allergies (42)
Alliances (8254)
ALS (53)
Alzheimer's disease (351)
Antibody-drug conjugate (ADC) (153)
Approvals (1992)
Artificial intelligence (237)
ASCO (58)
Autoimmune disease (92)
Automation (11)
Bankruptcy (55)
Belgium (6)
Best Places to Work (1203)
BIO (23)
Biologics (16)
BIOSECURE Act (9)
Biosimilars (94)
BioSpace Insights (66)
Biotechnology (14)
Bispecific (7)
Bladder cancer (42)
Brain cancer (12)
Breast cancer (78)
Cancer (1135)
Cardiovascular disease (179)
Career advice (471)
Career pathing (31)
CAR-T (68)
CDC (13)
CDMO (96)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (167)
Cervical cancer (5)
Clinical research (11331)
Collaboration (593)
Commercialization (19)
Company closure (3)
Compensation (137)
Complete response letters (41)
COVID-19 (466)
CRISPR (10)
CRO (3)
C-suite (373)
Cystic fibrosis (17)
Data (1195)
Decentralized trials (2)
Denatured (14)
Depression (42)
Dermatology (46)
Diabetes (142)
Diagnostics (556)
Digital health (14)
Diversity (8)
Diversity, equity & inclusion (11)
Drug discovery (141)
Drug pricing (169)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (10317)
Editorial (49)
Employer branding (6)
Employer resources (51)
ESMO (35)
Events (12830)
Executive appointments (294)
Eye disease (4)
FDA (2627)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (392)
Gene editing (33)
Generative AI (43)
Gene therapy (149)
GLP-1 (515)
Government (861)
Grass and pollen (1)
Guidances (48)
Healthcare (1560)
Hematology (28)
HIV (19)
Huntington's disease (20)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (21)
Immunology and inflammation (180)
Immuno-oncology (51)
Indications (25)
Infectious disease (566)
Inflammatory bowel disease (49)
Inflation Reduction Act (6)
Influenza (30)
Intellectual property (50)
Interviews (79)
IPO (2134)
IRA (42)
Job creations (851)
Job search strategy (391)
JPM (39)
Kidney cancer (3)
Kidney disease (29)
Labor market (92)
Layoffs (252)
Leadership (35)
Legal (1139)
Licensing (35)
Liver cancer (21)
Longevity (7)
Lung cancer (162)
Lung diease (8)
Lymphoma (101)
Machine learning (17)
Management (24)
Manufacturing (441)
Marketing (8)
MASH (59)
Medical device (422)
Medtech (431)
Mergers & acquisitions (4118)
Metabolic disorders (628)
Middle East (1)
mRNA (63)
Multiple sclerosis (46)
Multispecific (2)
NASH (9)
Netherlands (8)
Neurodegenerative disease (113)
Neuropsychiatric disorders (55)
Neuroscience (787)
Neurotech (1)
NextGen: Class of 2026 (641)
Non-profit (151)
Now hiring (60)
Obesity (440)
Opinion (174)
Ovarian cancer (25)
Pain (83)
Pancreatic cancer (74)
Parkinson's disease (75)
Partnered (12)
Patents (141)
Patient advocacy (1)
Patient recruitment (105)
Patient selection (11)
Peanut (7)
People (10779)
Peptides (5)
Pharmaceutical (12)
Pharmacy benefit managers (22)
Phase 1 (3132)
Phase 2 (5132)
Phase 3 (4384)
Pipeline (2036)
Policy (203)
Postmarket research (289)
Preclinical (1070)
Press Release (5)
Prostate cancer (68)
Psychedelics (35)
Radiopharmaceuticals (100)
Rare diseases (321)
Real estate (981)
Recruiting (23)
Regulatory (4215)
Reports (17)
Research institute (225)
Resumes & cover letters (100)
Rett syndrome (1)
RNA editing (11)
RSV (30)
Schizophrenia (78)
Series A (70)
Series B (47)
Service/supplier (2)
Sickle cell disease (18)
Special edition (25)
Spinal muscular atrophy (44)
Sponsored (10)
Startups (757)
Stem cells (1)
Stomach cancer (11)
Substance use disorders (5)
Supply chain (55)
Switzerland (5)
Tariffs (94)
Tax incentives (1)
The Weekly (81)
Vaccines (230)
Venture capital (100)
Weight loss (359)
Women's health (35)
Women in leadership (1)
Worklife (11)
Date
Today (26)
Last 7 days (137)
Last 30 days (511)
Last 365 days (4784)
2026 (4282)
2025 (4739)
2024 (5247)
2023 (5759)
2022 (8121)
2021 (7644)
2020 (6678)
2019 (5441)
2018 (4344)
2017 (6180)
2016 (5388)
2015 (5378)
2014 (3325)
2013 (2861)
2012 (2889)
2011 (2852)
2010 (2397)
Location
Africa (186)
Alabama (6)
Arizona (19)
Arkansas (1)
Asia (9673)
Australia (950)
California (1532)
Canada (675)
China (423)
Colorado (97)
Connecticut (127)
Delaware (52)
Europe (21226)
Florida (420)
Georgia (14)
Hawaii (1)
Idaho (3)
Illinois (136)
India (68)
Indiana (66)
Iowa (2)
Japan (246)
Kansas (49)
Kentucky (3)
Louisiana (3)
Maryland (251)
Massachusetts (1283)
Michigan (29)
Minnesota (28)
Mississippi (2)
Missouri (4)
Montana (1)
Nebraska (3)
Nevada (11)
New Hampshire (3)
New Jersey (908)
New Mexico (16)
New York (437)
North Carolina (216)
Northern California (630)
Ohio (79)
Oklahoma (1)
Oregon (9)
Pennsylvania (459)
Puerto Rico (20)
Rhode Island (8)
South America (237)
South Carolina (3)
Southern California (752)
Tennessee (18)
Texas (152)
United States (6327)
Utah (26)
Virginia (27)
Washington D.C. (19)
Washington State (206)
West Virginia (1)
Wisconsin (19)
Wyoming (1)
93,510 Results for "recce pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Sun Pharma stops eye-care drug production at Indian plant amid quality issues
The cessation of manufacturing activities follows a Sun Pharma recall and reports that regulators found fault with the company’s quality system.
November 2, 2026
·
2 min read
·
Nick Paul Taylor
Job Trends
Behind the scenes of 3 Big Pharma layoffs
Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some aspects of their experiences, such as severance and outplacement resources, they criticized a lack of public transparency, a mishandled notification and puzzling outsourcing.
October 28, 2026
·
5 min read
·
Angela Gabriel
Mergers & acquisitions
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
The largest pharmas have a collective $188 billion in firepower to spend on M&A transactions, with all but one signaling a desire to execute, according to a new analysis from Leerink Partners.
October 28, 2026
·
3 min read
·
Annalee Armstrong
Job Trends
Pharmas face off for manufacturing talent amidst reshoring efforts
As pharmas reshore manufacturing, they’re squaring off with each other to find the right personnel to staff up their plants. That task is challenging given the limited talent pool, difficulty filling critical roles and, in some cases, competition from data centers.
September 23, 2026
·
5 min read
·
Angela Gabriel
Recce Pharmaceuticals Granted New Patent in China for RECCE® Anti-Infectives
Recce Pharmaceuticals Ltd. today announced the China National Intellectual Property Administration has formally granted Recce a new family two patent, “ Copolymer and Method for Treatment of Bacterial Infection , ” for its anti-infectives, with expiry in 2035.
May 8, 2024
·
3 min read
Recce Pharmaceuticals Reports Positive Preclinical Data of RECCE® 327 in Lung Infection Pilot Study
Recce Pharmaceuticals Ltd. today announced positive results from a preclinical pilot study evaluating nebulized RECCE® 327 (R327) for the treatment of lung infections in a mouse model.
May 13, 2024
·
4 min read
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Canada, Strengthening Global IP Portfolio
Recce Pharmaceuticals Ltd today announced it has been issued a trademark registration for RECCE ® from the Canadian Intellectual Property Office, strengthening its global intellectual property (IP) portfolio.
March 22, 2024
·
3 min read
Press Releases
Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-Infectives
February 27, 2025
·
3 min read
China
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
July 28, 2026
·
7 min read
·
Annalee Armstrong
Press Releases
Cosette Pharma’s RYANODEX® (dantrolene sodium) for Injectable Suspension, Fully Stocked and Available
November 10, 2026
·
2 min read
1 of 9,351
Next
